Women who experience menopause before the age of 40 face increased risks of premature death from cancer and heart disease, as found by a recent study in Finland. This study, presented at the 26th European Congress of Endocrinology in Stockholm, revealed that using hormone replacement therapy (HRT) for over six months may reduce the risk of all-cause and cancer-related mortality by half. Researchers emphasized the importance of raising awareness among healthcare professionals and affected women. Premature ovarian insufficiency (POI), leading to early menopause, affects about 1% of women due to various factors like genetic disorders or surgery. A study compared outcomes of women with POI to those without, highlighting the elevated risks of cancer and heart disease for the former. Hormone replacement therapy is a common treatment for POI but is underutilized. Future research aims to explore the impact of long-term HRT on overall health outcomes for POI patients. Overall, this study sheds light on the link between premature menopause and mortality risks, emphasizing the need for early intervention and proper management strategies.
